Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines
NCT04830345
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
290
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
ATGC-100 100U
BIOLOGICAL:
Botox 100U
Sponsor
EuBiologics Co.,Ltd